Key Insights

Highlights

Success Rate

76% trial completion

Published Results

11 trials with published results (18%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

16.1%

10 terminated out of 62 trials

Success Rate

75.6%

-10.9% vs benchmark

Late-Stage Pipeline

24%

15 trials in Phase 3/4

Results Transparency

35%

11 of 31 completed with results

Key Signals

11 with results76% success

Data Visualizations

Phase Distribution

41Total
Not Applicable (14)
Early P 1 (1)
P 1 (5)
P 2 (6)
P 3 (4)
P 4 (11)

Trial Status

Completed31
Unknown14
Terminated10
Withdrawn4
Recruiting3

Trial Success Rate

75.6%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT07359287Not ApplicableRecruitingPrimary

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

NCT05786417Phase 4RecruitingPrimary

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

NCT06212466Completed

MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)

NCT05634031Not ApplicableRecruitingPrimary

Imaging Coronary Microvascular Dysfunction (CMD) Study

NCT05147766Phase 1Terminated

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease

NCT06139094Completed

MCG for Suspected INOCA Confirmed by Thermodilution-Derived CFR

NCT02032030Completed

Systematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys

NCT04097912Completed

Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels

NCT05018715Unknown

Research on the Diagnostic Value of Machine Learning Model Based on Clinical Data in Patients With Coronary Heart Disease

NCT00159718Phase 4CompletedPrimary

Double Blind Atorvastatin Amlodipine Study

NCT02545231Phase 4Completed

Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis

NCT02832115Phase 4Completed

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

NCT02341664Completed

Patient and Provider Assessment of Lipid Management Registry

NCT01721096CompletedPrimary

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

NCT01890525Completed

PROMISE Substudy to Assess For Effective Dose of Radiation (PROMISE-SAFER) Specific Aim 3b

NCT02337348Not ApplicableTerminated

Prospective Randomized Optical Coherence Tomography Oslo tRial

NCT02265796Phase 2CompletedPrimary

Ranolazine Among Unrevascularized Chronic Stable Angina Patients

NCT02648230Not ApplicableCompleted

PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evaluation of FFR Measurements

NCT02147834Phase 2TerminatedPrimary

Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents

NCT03401502Not ApplicableCompletedPrimary

A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency

Scroll to load more

Research Network

Activity Timeline